DA Davidson analyst Matt Summerville raised the firm’s price target on Ametek (AME) to $215 from $210 and keeps a Buy rating on the shares after its Q2 earnings beat. The firm is raising its 2025 and 2026 estimates, reflecting a modest level of initial accretion with respect to FARO Technologies acquisition and continued improvements within Paragon Medical and its automation business, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AME: